Effect of Tidal Volume Change on Pressure-based Prediction of Fluid Responsiveness in Children

May 4, 2022 updated by: Jin-Tae Kim, Seoul National University Hospital
This study evaluates predictability of fluid responsiveness of pressure-based dynamic variables such as pulse pressure variation and systolic pressure variation, according to tidal volume change in patients undergoing cardiac surgery.

Study Overview

Detailed Description

Pressure-based dynamic variables such as pulse pressure variation(PPV) and systolic pressure variation(SPV) are known to be unreliable for prediction of fluid responsiveness in children.

The hypothesis is that tidal volume change in mechanically ventilated children undergoing anesthesia would affect reliability of aforementioned dynamic variables in prediction of fluid responsiveness, especially in the way that reliability increases for high tidal volume.

In children undergoing cardiac surgery, tidal volume is changed to 6mL/kg, 10mL/kg and 14mL/kg after closure of sternum, followed by measurement of PPV, SPV. We also measure the respiratory variation of aortic blood peak velocity(△Vpeak) via transesophageal echocardiography, which is known to best predict fluid responsiveness.

Afterward, 10mL/kg of crystalloid solution is administered for fluid loading. 'Fluid responder' is defined as subjects with increase of stroke volume index more than 15% after fluid loading of 10mL/kg.

With these data, whether the predictability of fluid responsiveness of PPV and SPV changes according to change in tidal volume is evaluated by comparing the area under the curve of the receiver-operating characteristics curve between themselves and △Vpeak.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 5 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Children younger than 6 years old planned to undergo ventricular septal defect closure or atrial septal defect closure under general anesthesia

Exclusion Criteria:

  • Children with other complex cardiac defects
  • Children with arrhythmia
  • Children with preoperatively measured ejection fraction of less than 30%
  • Children with underlying pulmonary disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SCREENING
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Study group

Measure pulse pressure variation and systolic pressure variation after each set of tidal volume to 6mL/kg, 10mL/kg and 14mL/kg. Measure respiratory variation of aortic blood flow peak velocity via transesophageal echocardiography at tidal volume of 10mL/kg.

Measure stroke volume index via transesophageal echocardiography before and 5 min after fluid loading with 10mL/kg of crystalloid.

Set tidal volume to 6mL/kg for 1 minute
Set tidal volume to 10mL/kg for 1 minute
Set tidal volume to 10mL/kg for 1 minute
Administer 10mL/kg of crystalloid for 5 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stroke volume index
Time Frame: From sternal closure to 5 minutes after fluid loading
Define subject that shows increase of stroke volume index more than 15% after 10mL/kg of fluid loading as fluid responder, otherwise as non-responder
From sternal closure to 5 minutes after fluid loading
Predictability_PPV and SPV
Time Frame: From sternal closure to 5 minutes after fluid loading
Area under the curve of the receiver-operative characteristic curve for prediction of fluid responder of pulse pressure variation and systolic pressure variation after each change of set tidal volume
From sternal closure to 5 minutes after fluid loading

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Predictability_△Vpeak
Time Frame: From sternal closure to 5 minutes after fluid loading
Area under the curve of the receiver-operative characteristic curve for prediction of fluid responder of respiratory variation of aortic blood flow peak velocity measured via transesophageal echocardiography at tidal volume of 10mL/kg
From sternal closure to 5 minutes after fluid loading
Grey zone
Time Frame: From sternal closure to 5 minutes after fluid loading
Compare the range that the prediction of fluid responsiveness is unreliable (grey zone) for each variable in each set tidal volume
From sternal closure to 5 minutes after fluid loading

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate
Time Frame: From start of anesthesia to end of anesthesia
Heart rate determined by electrocardiogram (beats/min)
From start of anesthesia to end of anesthesia
Pulse oximetry
Time Frame: From start of anesthesia to end of anesthesia
Pulse oximetry determined by photoplethysmography (%)
From start of anesthesia to end of anesthesia
End-tidal carbon dioxide
Time Frame: From start of anesthesia to end of anesthesia
End-tidal carbon dioxide measured from ventilatory circuit (mmHg)
From start of anesthesia to end of anesthesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jin-Tae Kim, M.D, Ph.D., Seoul National University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 30, 2019

Primary Completion (ACTUAL)

June 23, 2020

Study Completion (ACTUAL)

October 6, 2020

Study Registration Dates

First Submitted

May 19, 2019

First Submitted That Met QC Criteria

May 22, 2019

First Posted (ACTUAL)

May 24, 2019

Study Record Updates

Last Update Posted (ACTUAL)

May 5, 2022

Last Update Submitted That Met QC Criteria

May 4, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 1902-119-1013

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Plasma Volume

Clinical Trials on Tidal volume_6mL/kg

3
Subscribe